Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Significant predictors included prognostic risk of chronicity (Start Back) (MC [CI] high/low -0.6[-1.4,0.3]; MC [CI] medium/low –0.4[-1.1, 0.3]), age (for an increase of 10 years, 0.2[0.0,0.4]), sex was borderline significant (95% CI is -0.99 to 0.05) and baseline disability (Oswestry Disability index- increase of 20 units (-0.5[-0.9, -0.1]).
In the multivariable model including patients with HER2 + ABC, the following variables had a significant (≤ 0.05) or borderline significant (≤ 0.10) impact on OS: age at ABC diagnosis (hazard ratio per year 1.01, 95% CI 1.01–1.02), WHO performance status ≥ 2 (hazard ratio 2.29, 95% CI 1.58–3.32), WHO performance status unknown (hazard ratio 1.61, 95% CI 1.27–2.05), multiple initial metastatic sites (hazard ratio 1.68, 95% CI 1.25–2.25), and MFI 3–23 months (hazard ratio 1.56, 95% CI 1.12–2.19) (Table 2 ).
In multivariate analysis, HER2 + (versus HER2 - ) status was associated with poor BC-SS for non-T4 patient cases (hazards ratio = 1.16, 95% confidence interval 1.05 to 1.28) and had a borderline significant association with improved BC-SS for IBC (hazards ratio = 0.82, 95% confidence interval = 0.68 to 0.99).
Discussion The main results of our in-vitro investigations are that, in HAEC, TLR4 antagonism with eritoran: 1) inhibits LPS-induced mRNA expression of the inflammatory cytokines IL-6, IL-8, TNFα, and CCL-2, and of the adhesion molecules VCAM and ICAM; 2) inhibits ox-PAPC-induced mRNA expression of IL-8 and of IL-6, albeit to a borderline significant level; and 3) reduces LPS-induced phosphorylation of NF-κB p65 subunit and IκB-α.